Akebia Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA), a biopharmaceutical company focused on kidney disease, announced that CEO John P. Butler will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 4:30 p.m. ET. The presentation will be virtual, and an audio replay will be available on Akebia's investor website for 30 days post-event. Founded in 2007 and headquartered in Cambridge, Massachusetts, Akebia aims to enhance the lives of those impacted by kidney disease.

CAMBRIDGE, Mass., Jan. 4, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, will present virtually at the 40^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 4:30 p.m. ET.

An audio replay of the presentation will be available through the Investors section of Akebia's website at https://ir.akebia.com for approximately 30 days following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
Mcarrasco@akebia.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-40th-annual-jp-morgan-healthcare-conference-301452956.html

SOURCE Akebia Therapeutics

FAQ

When will Akebia Therapeutics present at the J.P. Morgan Healthcare Conference?

Akebia Therapeutics will present on January 11, 2022, at 4:30 p.m. ET.

Who is presenting for Akebia Therapeutics at the conference?

CEO John P. Butler will be presenting for Akebia Therapeutics.

How can I access the replay of Akebia's conference presentation?

The audio replay will be available on Akebia's investor website for 30 days after the presentation.

What is the purpose of Akebia Therapeutics?

Akebia Therapeutics aims to improve the lives of individuals affected by kidney disease.

Where is Akebia Therapeutics headquartered?

Akebia Therapeutics is headquartered in Cambridge, Massachusetts.